Ilex Medical Cash Flow Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	55.56	38.98	50.89	102.12	197.48
Depreciation & Amortization	49.5	47.46	46.53	50.04	50.49
Other Amortization	-	1.64	1.2	-	-
Loss (Gain) From Sale of Assets	-0.13	0.46	-0.26	-21.96	0.01
Loss (Gain) From Sale of Investments	-6.74	-3.47	-4.12	2.84	-3.68
Loss (Gain) on Equity Investments	10.63	7.19	4.01	2.69	0.26
Other Operating Activities	14.85	12.51	-10.89	-24.42	25.16
Change in Accounts Receivable	-17.9	32.14	-56	-23.9	21.28
Change in Inventory	-35.27	-0.22	-14.13	-27.71	20.89
Change in Accounts Payable	21.6	-43.96	32.49	10.6	-20.22
Change in Unearned Revenue	-64.51	3.77	96.58	-	-
Change in Other Net Operating Assets	45.27	-8.16	-61.21	5.79	-21
Operating Cash Flow	72.87	81.63	80.43	69.74	270.68
Operating Cash Flow Growth	-10.73%	1.49%	15.33%	-74.23%	48.39%
Capital Expenditures	-26.98	-29.76	-48.77	-26.14	-40.94
Sale of Property, Plant & Equipment	0.15	0.28	0.17	0.08	1.06
Cash Acquisitions	-	-	-	-10.51	-
Divestitures	-	1.94	-	-	-
Sale (Purchase) of Intangibles	-3.08	-3.58	-3.39	-2.22	-1.7
Sale (Purchase) of Real Estate	-	-	-	43	-
Investment in Securities	-33.99	8.18	-38.68	-50.78	-38.1
Other Investing Activities	17.25	-	-	-7.07	-2.78
Investing Cash Flow	-46.65	-22.94	-90.68	-53.64	-82.45
Short-Term Debt Repaid	-	-	-	-	-0.22
Long-Term Debt Repaid	-13.68	-13.63	-13.56	-13.71	-26.56
Total Debt Repaid	-13.68	-13.63	-13.56	-13.71	-26.77
Net Debt Issued (Repaid)	-13.68	-13.63	-13.56	-13.71	-26.77
Repurchase of Common Stock	-	-	-5.72	-3.49	-
Common Dividends Paid	-13.64	-15.27	-21.44	-60	-60
Other Financing Activities	-	-	-	-0.1	-0.01
Financing Cash Flow	-27.33	-28.89	-40.72	-77.3	-86.78
Foreign Exchange Rate Adjustments	-0.55	-0.93	-1.61	2.92	-2.04
Net Cash Flow	-1.66	28.87	-52.57	-58.28	99.41
Free Cash Flow	45.89	51.87	31.66	43.6	229.73
Free Cash Flow Growth	-11.53%	63.83%	-27.38%	-81.02%	66.35%
Free Cash Flow Margin	4.93%	5.64%	3.46%	5.05%	21.65%
Free Cash Flow Per Share	4.11	4.64	2.83	3.87	20.36
Cash Interest Paid	-	2.35	1.8	1.61	1.93
Cash Income Tax Paid	-	14.04	34.31	76.77	30.79
Levered Free Cash Flow	32.46	29.62	36.78	35.97	168.57
Unlevered Free Cash Flow	34.98	31.08	37.89	36.95	169.8
Change in Working Capital	-50.81	-16.43	-2.28	-35.22	0.95

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.